Antiplasmodial, Trypanocidal, and Genotoxicity

antiparasitic activity atorvastatin chemical synthesis drug development genotoxicity assessment hybrid compounds phenylacetamides

Journal

Pharmaceuticals (Basel, Switzerland)
ISSN: 1424-8247
Titre abrégé: Pharmaceuticals (Basel)
Pays: Switzerland
ID NLM: 101238453

Informations de publication

Date de publication:
24 May 2023
Historique:
received: 16 04 2023
revised: 13 05 2023
accepted: 19 05 2023
medline: 28 6 2023
pubmed: 28 6 2023
entrez: 28 6 2023
Statut: epublish

Résumé

Statins present a plethora of pleiotropic effects including anti-inflammatory and antimicrobial responses. A,α-difluorophenylacetamides, analogs of diclofenac, are potent pre-clinical anti-inflammatory non-steroidal drugs. Molecular hybridization based on the combination of pharmacophoric moieties has emerged as a strategy for the development of new candidates aiming to obtain multitarget ligands. Considering the anti-inflammatory activity of phenylacetamides and the potential microbicidal action of statins against obligate intracellular parasites, the objective of this work was to synthesize eight new hybrid compounds of α,α-difluorophenylacetamides with the moiety of statins and assess their phenotypic activity against None of the sodium salt compounds presented antiparasitic activity and two acetated compounds displayed mild anti- However, the chlorinated derivative was the most promising compound with chemical and biological profitable characteristics, without presenting genotoxicity

Sections du résumé

BACKGROUND BACKGROUND
Statins present a plethora of pleiotropic effects including anti-inflammatory and antimicrobial responses. A,α-difluorophenylacetamides, analogs of diclofenac, are potent pre-clinical anti-inflammatory non-steroidal drugs. Molecular hybridization based on the combination of pharmacophoric moieties has emerged as a strategy for the development of new candidates aiming to obtain multitarget ligands.
METHODS METHODS
Considering the anti-inflammatory activity of phenylacetamides and the potential microbicidal action of statins against obligate intracellular parasites, the objective of this work was to synthesize eight new hybrid compounds of α,α-difluorophenylacetamides with the moiety of statins and assess their phenotypic activity against
RESULTS RESULTS
None of the sodium salt compounds presented antiparasitic activity and two acetated compounds displayed mild anti-
CONCLUSIONS CONCLUSIONS
However, the chlorinated derivative was the most promising compound with chemical and biological profitable characteristics, without presenting genotoxicity

Identifiants

pubmed: 37375730
pii: ph16060782
doi: 10.3390/ph16060782
pmc: PMC10301432
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
ID : E-26/202.805/2017
Organisme : Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
ID : E-26/200.839/2021
Organisme : Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
ID : E-26/010.002119/2019
Organisme : Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
ID : E-26/010.100956/2018
Organisme : Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
ID : E-26/210.096/2023
Organisme : Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
ID : E-26/200.825/2021
Organisme : Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
ID : E-26/202.925/2017
Organisme : National Council for Scientific and Technological Development
ID : 302345/2017-5
Organisme : National Council for Scientific and Technological Development
ID : 306193/2018-3
Organisme : National Council for Scientific and Technological Development
ID : 302160/2019
Organisme : Coordenação de Aperfeicoamento de Pessoal de Nível Superior
ID : 0001

Références

Bioorg Med Chem Lett. 2016 Apr 15;26(8):1881-4
pubmed: 26988303
Biochem Biophys Res Commun. 1990 Feb 14;166(3):1441-5
pubmed: 2407242
Mem Inst Oswaldo Cruz. 2015 Jun;110(4):492-9
pubmed: 26018452
Int J Biol Sci. 2020 Aug 13;16(14):2704-2711
pubmed: 33110390
Rev Argent Microbiol. 2023 Apr 3;:
pubmed: 37019801
Am J Trop Med Hyg. 2011 Feb;84(2):325-31
pubmed: 21292909
J Parasitol. 1979 Jun;65(3):418-20
pubmed: 383936
SAR QSAR Environ Res. 2014;25(1):17-33
pubmed: 24283490
Antimicrob Agents Chemother. 1993 Mar;37(3):580-91
pubmed: 8460926
Antimicrob Agents Chemother. 2010 Feb;54(2):966-7
pubmed: 19949060
Antimicrob Agents Chemother. 2008 Nov;52(11):4203-4
pubmed: 18779350
Curr Top Med Chem. 2016;16(20):2266-89
pubmed: 27072716
Pathogens. 2022 Jun 02;11(6):
pubmed: 35745497
Antimicrob Agents Chemother. 2009 May;53(5):2212-4
pubmed: 19258270
Antimicrob Agents Chemother. 2014 Jul;58(7):3720-6
pubmed: 24752263
Arch Biochem Biophys. 1998 Apr 1;352(1):114-20
pubmed: 9521823
Exp Parasitol. 1988 Jun;66(1):86-95
pubmed: 3284758
Malar J. 2011 Feb 28;10:52
pubmed: 21356073
Toxicol In Vitro. 2007 Dec;21(8):1650-5
pubmed: 17728095
Expert Opin Drug Metab Toxicol. 2020 Sep;16(9):809-822
pubmed: 32729746
Mutat Res. 1995 Jun;343(2-3):95-107
pubmed: 7791813
Pharmacol Ther. 2020 Apr;208:107483
pubmed: 31953128
Pharmacol Res. 2014 Oct;88:3-11
pubmed: 24657242
Mem Inst Oswaldo Cruz. 2010 Mar;105(2):233-8
pubmed: 20428688
PLoS Pathog. 2013;9(10):e1003665
pubmed: 24146616
Eur J Cell Biol. 1986 Aug;41(2):198-206
pubmed: 3093234
Antimicrob Agents Chemother. 2009 Jun;53(6):2248-52
pubmed: 19307369
Bioorg Med Chem Lett. 2004 Mar 8;14(5):1145-9
pubmed: 14980653
Parasitology. 2014 Jan;141(1):140-6
pubmed: 23985066
Antimicrob Agents Chemother. 2018 Aug 27;62(9):
pubmed: 29987140
J Ethnopharmacol. 2021 Sep 15;277:114217
pubmed: 34038800
Toxicol Sci. 2001 Oct;63(2):151-2
pubmed: 11568356
Antimicrob Agents Chemother. 2013 Sep;57(9):4151-63
pubmed: 23774435
Farmaco. 2001 Aug;56(8):565-70
pubmed: 11601641
PLoS Pathog. 2012 Dec;8(12):e1003099
pubmed: 23300448
Mem Inst Oswaldo Cruz. 2012 Jun;107(4):513-21
pubmed: 22666863
Malar J. 2013 Aug 30;12:302
pubmed: 23988087
Acta Trop. 2023 Jun;242:106924
pubmed: 37037291
Antimicrob Agents Chemother. 2014 Jul;58(7):4191-5
pubmed: 24590476
Fed Regist. 2012 Jun 7;77(110):33748-9
pubmed: 22675782
Mol Biol Cell. 2004 Mar;15(3):1356-63
pubmed: 14699057
Science. 1976 Aug 20;193(4254):673-5
pubmed: 781840
Mutat Res. 2011 Sep 18;724(1-2):7-21
pubmed: 21658468
Mem Inst Oswaldo Cruz. 2022 Mar 14;117:e220004
pubmed: 35293439
Mutat Res. 1983 May;113(3-4):173-215
pubmed: 6341825
Oxid Med Cell Longev. 2018 Apr 3;2018:7820890
pubmed: 29849914

Auteurs

Carlos Fernando Araujo-Lima (CF)

Laboratório de Biologia Celular, LBC Instituto Oswaldo Cruz-FIOCRUZ, Rio de Janeiro 21041-250, RJ, Brazil.
Laboratório de Mutagênese Ambiental, LabMut Instituto de Biologia Roberto Alcantara Gomes, IBRAG-UERJ, Rio de Janeiro 22050-020, RJ, Brazil.
Programa de Pós-Graduação em Biologia Molecular e Celular, Instituto Biomédico-UNIRIO, Rio de Janeiro 20211-030, RJ, Brazil.

Rita de Cassia Castro Carvalho (R)

Departamento de Síntese de Fármacos, Instituto de Tecnologia em Fármacos, Farmanguinhos-FIOCRUZ, Rua Sizenando Nabuco 100, Manguinhos, Rio de Janeiro 21041-250, RJ, Brazil.
Programa de Pós-Graduação em Química, PGQu, Instituto de Química, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-853, RJ, Brazil.

Sandra Loureiro Rosario (SL)

Departamento de Síntese de Fármacos, Instituto de Tecnologia em Fármacos, Farmanguinhos-FIOCRUZ, Rua Sizenando Nabuco 100, Manguinhos, Rio de Janeiro 21041-250, RJ, Brazil.

Debora Inacio Leite (DI)

Departamento de Síntese de Fármacos, Instituto de Tecnologia em Fármacos, Farmanguinhos-FIOCRUZ, Rua Sizenando Nabuco 100, Manguinhos, Rio de Janeiro 21041-250, RJ, Brazil.
Programa de Pós-Graduação em Farmacologia e Química Medicinal, ICB-UFRJ, Rio de Janeiro 21941-902, RJ, Brazil.

Anna Caroline Campos Aguiar (ACC)

Laboratório de Malária, Centro de Pesquisas René Rachou, CPqRR-FIOCRUZ, Belo Horizonte 30190-002, MG, Brazil.

Lizandra Vitoria de Souza Santos (LV)

Laboratório de Mutagênese Ambiental, LabMut Instituto de Biologia Roberto Alcantara Gomes, IBRAG-UERJ, Rio de Janeiro 22050-020, RJ, Brazil.

Julianna Siciliano de Araujo (JS)

Laboratório de Biologia Celular, LBC Instituto Oswaldo Cruz-FIOCRUZ, Rio de Janeiro 21041-250, RJ, Brazil.

Kelly Salomão (K)

Laboratório de Biologia Celular, LBC Instituto Oswaldo Cruz-FIOCRUZ, Rio de Janeiro 21041-250, RJ, Brazil.

Carlos Roland Kaiser (CR)

Programa de Pós-Graduação em Química, PGQu, Instituto de Química, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-853, RJ, Brazil.

Antoniana Ursine Krettli (AU)

Laboratório de Malária, Centro de Pesquisas René Rachou, CPqRR-FIOCRUZ, Belo Horizonte 30190-002, MG, Brazil.

Monica Macedo Bastos (MM)

Departamento de Síntese de Fármacos, Instituto de Tecnologia em Fármacos, Farmanguinhos-FIOCRUZ, Rua Sizenando Nabuco 100, Manguinhos, Rio de Janeiro 21041-250, RJ, Brazil.

Claudia Alessandra Fortes Aiub (CAF)

Programa de Pós-Graduação em Biologia Molecular e Celular, Instituto Biomédico-UNIRIO, Rio de Janeiro 20211-030, RJ, Brazil.

Maria de Nazaré Correia Soeiro (M)

Laboratório de Biologia Celular, LBC Instituto Oswaldo Cruz-FIOCRUZ, Rio de Janeiro 21041-250, RJ, Brazil.

Nubia Boechat (N)

Departamento de Síntese de Fármacos, Instituto de Tecnologia em Fármacos, Farmanguinhos-FIOCRUZ, Rua Sizenando Nabuco 100, Manguinhos, Rio de Janeiro 21041-250, RJ, Brazil.

Israel Felzenszwalb (I)

Laboratório de Mutagênese Ambiental, LabMut Instituto de Biologia Roberto Alcantara Gomes, IBRAG-UERJ, Rio de Janeiro 22050-020, RJ, Brazil.

Classifications MeSH